Minnie Au

Minnie Au

Auto-generated profile, based on publicly available information

Minnie Au

Department of Gastroenterology Lyell McEwin Hospital Adelaide South Australia Australia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2016 in Clinical Science
Verified
Journal Article
Closed access
PDF file
Theophilus I EmetoTheophilus I Emeto
Theophilus I Emeto
Joe MoxonJoe Moxon
Joe Moxon
MAMinnie Au
Minnie Au
Jonathan GolledgeJonathan Golledge
Jonathan Golledge
Abdominal aortic aneurysm (AAA) is a significant cause of mortality in older adults. A key mechanism implicated in AAA pathogenesis is inflammation and the associated production of reactive oxygen species (ROS) and oxidative stress. These have been suggested to promote degradation of the extracellular matrix (ECM) and vascular smooth muscle apoptosis. Experimental and human association studies suggest that ROS can be favourably modified to limit AAA formation and progression. In the present review, we discuss mechanisms potentially linking ROS to AAA pathogenesis and highlight potential treatment strategies targeting ROS. Currently, none of these strategies has been shown to be effective in clinical practice.

19 August 2016 in Biomedicines
Verified
Journal Article
Open access
PDF file
MAMinnie Au
Minnie Au
Theophilus I EmetoTheophilus I Emeto
Theophilus I Emeto
JPJacinta Power
Jacinta Power
VVVenkat N. Vangaveti
Venkat N. Vangaveti
HLHock C. Lai
Hock C. Lai
Pancreatic cancer is an aggressive disease with a five year survival rate of less than 5%, which is associated with late presentation. In recent years, research into nanomedicine and the use of nanoparticles as therapeutic agents for cancers has increased. This article describes the latest developments in the use of nanoparticles, and evaluates the risks and benefits of nanoparticles as an emerging therapy for pancreatic cancer. The Preferred Reporting Items of Systematic Reviews and Meta-Analyses checklist was used. Studies were extracted by searching the Embase, MEDLINE, SCOPUS, Web of Science, and Cochrane Library databases from inception to 18 March 2016 with no language restrictions. Clinical trials involving the use of nanoparticles as a therapeutic or prognostic option in patients with pancreatic cancer were considered. Selected studies were evaluated using the Jadad score for randomised control trials and the Therapy CA Worksheet for intervention studies. Of the 210 articles found, 10 clinical trials including one randomised control trial and nine phase I/II clinical trials met the inclusion criteria and were analysed. These studies demonstrated that nanoparticles can be used in conjunction with chemotherapeutic agents increasing their efficacy whilst reducing their toxicity. Increased efficacy of treatment with nanoparticles may improve the clinical outcomes and quality of life in patients with pancreatic cancer, although the long-term side effects are yet to be defined. The study registration number is CRD42015020009.

30 September 2022 in Internal Medicine Journal
Verified
Journal Article
Closed access
MAMinnie Au
Minnie Au
GHGeorgina Heddle
Georgina Heddle
EYEdward Young
Edward Young
EREmma Ryan
Emma Ryan
SGScott Graf
Scott Graf
HPHamish Philpott
Hamish Philpott

27 May 2021 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
MAMinnie Au
Minnie Au
ABAmy Body
Amy Body
AMAndrew Mant
Andrew Mant
ANAmanda Nicoll
Amanda Nicoll

20 July 2015 in Medical Journal of Australia
Verified
Journal Article
Closed access
MAMinnie Au
Minnie Au
JWJohn Wood
John Wood
Gout can affect the spine, looking suspiciously like osteomyelitis

20 March 2022 in Internal Medicine Journal
Verified
Journal Article
Closed access
MAMinnie Au
Minnie Au
ARArvind Rajagopalan
Arvind Rajagopalan
DTDerrick Tee
Derrick Tee
HPHamish Philpott
Hamish Philpott